Upgrade to SI Premium - Free Trial

Piper Jaffray Cuts Price Target on Cepheid (CPHD) Following Preliminary 3Q Results

October 14, 2015 9:12 AM
Piper Jaffray maintained an Overweight rating on Cepheid (NASDAQ: CPHD), and cut the price target to $62.00 (from $66.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles